Could a simple shot replace monthly IV infusions for kidney transplant patients?
Disease control
Completed
This study looked at whether kidney transplant recipients can safely switch from monthly intravenous belatacept to weekly self-injected abatacept to prevent organ rejection. Sixteen adults who were 8-20 weeks post-transplant took part. Researchers checked how well patients could …
Phase: PHASE1 • Sponsor: Idelberto Badell • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC